Cancer Causes & Control

, Volume 28, Issue 1, pp 5–12 | Cite as

Trends in published meta-analyses in cancer research, 2008–2013

  • Ximena V. Qadir
  • Mindy Clyne
  • Tram Kim Lam
  • Muin J. Khoury
  • Sheri D. Schully
Original paper


In order to capture trends in the contribution of epidemiology to cancer research, we describe an online meta-analysis database resource for cancer clinical and population research and illustrate trends and descriptive detail of cancer meta-analyses from 2008 through 2013. A total of 4,686 cancer meta-analyses met our inclusion criteria. During this 6-year period, a fivefold increase was observed in the yearly number of meta-analyses. Fifty-six percent of meta-analyses concerned observational studies, mostly of cancer risk, more than half of which were genetic studies. The major cancer sites were breast, colorectal, and digestive. This online database for Cancer Genomics and Epidemiology Navigator will be continuously updated to allow investigators to quickly navigate the meta-analyses emerging from cancer epidemiology studies and cancer clinical trials.


Meta-analysis Database Epidemiology Clinical trials 



Ximena V. Qadir conducted the analyses and drafted the manuscript. Mindy Clyne conducted additional data analyses and prepared Methods section of the text. Tram Kim Lam prepared Discussion section of the text. Muin J. Khoury drafted Discussion section of the text and revised it for important intellectual content and contribution to the field of Epidemiology. Sheri D. Schully contributed significantly to the design of the project and supervised field activities. Significant effort and contribution was made from all authors.

Compliance with ethical standards

Conflict of interest

Authors have no conflict of interests to disclose.

Supplementary material

10552_2016_830_MOESM1_ESM.pdf (82 kb)
Supplementary material 1 (PDF 81 kb)
10552_2016_830_MOESM2_ESM.pdf (133 kb)
Supplementary material 2 (PDF 132 kb)


  1. 1.
    Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD (2013) Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomark Prev 22(4):508–516. doi: 10.1158/1055-9965.EPI-13-0146 CrossRefGoogle Scholar
  2. 2.
    Panagiotou OA, Willer CJ, Hirschhorn JN, Ioannidis JP (2013) The power of meta-analysis in genome-wide association studies. Annu Rev Genomics Hum Genet 14:441–465. doi: 10.1146/annurev-genom-091212-153520 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Evangelou E, Ioannidis JP (2013) Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet 14(6):379–389. doi: 10.1038/nrg3472 CrossRefPubMedGoogle Scholar
  4. 4.
    World Cancer Research Fund-American Institute for Cancer Research Diet and Cancer Report Cancer Prevention Recommendations. Accessed 4 Dec 4 2014
  5. 5.
    Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN (2014) Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. Ann Oncol 25(1):16–23. doi: 10.1093/annonc/mdt372 CrossRefPubMedGoogle Scholar
  6. 6.
    Murad MH, Montori VM, Ioannidis JP, Jaeschke R, Devereaux PJ, Prasad K, Neumann I, Carrasco-Labra A, Agoritsas T, Hatala R, Meade MO, Wyer P, Cook DJ, Guyatt G (2014) How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA 312(2):171–179. doi: 10.1001/jama.2014.5559 CrossRefPubMedGoogle Scholar
  7. 7.
    Schully SD, Rogers SD, Lam TK, Chang CQ, Clyne M, Cyr J, Watson D, Khoury MJ (2014) The Cancer Genomics and Epidemiology Navigator: an NCI online tool to enhance cancer epidemiology research. Cancer Epidemiol Biomark Prev 23(11):2610–2611. doi: 10.1158/1055-9965.EPI-14-0902 CrossRefGoogle Scholar
  8. 8.
    National Library of Medicine National Center for Biotechnology Information. Accessed 30 Oct 2014
  9. 9.
    Lin BK, Clyne M, Walsh M, Gomez O, Yu W, Gwinn M, Khoury MJ (2006) Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol 164(1):1–4. doi: 10.1093/aje/kwj175 CrossRefPubMedGoogle Scholar
  10. 10.
    Health NCIatNIo (2014) A Snapshot of Breast Cancer
  11. 11.
    Ioannidis JP, Chang CQ, Lam TK, Schully SD, Khoury MJ (2013) The geometric increase in meta-analyses from China in the genomic era. PLoS ONE 8(6):e65602. doi: 10.1371/journal.pone.0065602 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Yuan Y, Hunt RH (2009) Systematic reviews: the good, the bad, and the ugly. Am J Gastroenterol 104(5):1086–1092. doi: 10.1038/ajg.2009.118 CrossRefPubMedGoogle Scholar
  13. 13.
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. doi: 10.1371/journal.pmed.1000097 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology (MOOSE) group: a proposal for reporting. JAMA 283(15):2008–2012CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland (outside the USA) 2016

Authors and Affiliations

  • Ximena V. Qadir
    • 1
  • Mindy Clyne
    • 2
  • Tram Kim Lam
    • 1
  • Muin J. Khoury
    • 1
    • 3
  • Sheri D. Schully
    • 1
    • 4
  1. 1.Division of Cancer Control and Population Sciences, National Cancer InstituteNational Institutes of HealthBethesdaUSA
  2. 2.Kelly Government ServicesTroyUSA
  3. 3.Office of Public Health GenomicsCenters of Disease Control and PreventionAtlantaUSA
  4. 4.Office of Disease PreventionNational Institutes of HealthBethesdaUSA

Personalised recommendations